SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2003 / Cilt: 9 - Sayı: 6

Relation among Glycemia regulation, duration of diabetes and quality of life in patients with type 2 diabetes mellitus

Tip 2 diabetes mellituslu hastalarda glisemi ile yaşam kalitesi arasındaki ilişki

Muammer GÖZAYDIN
Tolga DUYGUN
İlhan SAYGILARLI
Nuri HAKSEVER
Pages
670–674
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that correlations between duration of diabetes and quality of life total score (r: 0.129, p<0.01), physical health (r:0.129, p<0.01), psychological health (r.0.129, p<0.01), social relation (r:0.194, p<0.05) which are factors of WHOQOL-BREF were statistically significant.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to investigate the relation among glycemia regulation, duration of diabetes and quality of life in patients with type 2 Diabetes Mellitus.
📊
Key Findings & Data:Material and Method: Participants in this study were consist of 108 patients with Type 2 Diabetes Mellitus who appealed to Merzifon Air Hospital Diabetes Clinic.
💡
Conclusion & Impact:The results showed that correlations between duration of diabetes and quality of life total score (r: 0.129, p<0.01), physical health (r:0.129, p<0.01), psychological health (r.0.129, p<0.01), social relation (r:0.194, p<0.05) which are factors of WHOQOL-BREF were statistically significant.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Yaşam kalitesi · Yaşlı · Diabetes mellitus

Abstract

Objective: The aim of this study is to investigate the relation among glycemia regulation, duration of diabetes and quality of life in patients with type 2 Diabetes Mellitus. Material and Method: Participants in this study were consist of 108 patients with Type 2 Diabetes Mellitus who appealed to Merzifon Air Hospital Diabetes Clinic. They were given Quality of Life Scale (WHOQOL-BREF) by psychologist via face to face procedure. Following glycemia, HbA1C, body mass index (BMI), cholesterol and triglycéride levels were measured and then investigated relation among quality of life scores (total score, whole health, physical health, psychological health, social relations and environmental relation), glycemia regulation, duration of diabetes and antidiabetic drugs. Results: Participants in this study were consist of 108 patients with Type 2 Diabetes Mellitus (68 female / 40 male, mean age: 60.54±10.33). The results of this study represent each parameter as follow, consecutively; mean duration of diabetes, BMI, HbA1C, glycemia, cholesterol and triglycéride were 7.07±6.17 year, 31.18+3.83 kg/m2, 7.62±1.56%, 166.56±47.03 mg/dl, 208.79±44.19 mg/dl, 142.92±66.27 mg/dl. The results showed that correlations between duration of diabetes and quality of life total score (r: 0.129, p<0.01), physical health (r:0.129, p<0.01), psychological health (r.0.129, p<0.01), social relation (r:0.194, p<0.05) which are factors of WHOQOL-BREF were statistically significant. The results showed that correlations between diabetic complications and quality of life total score (r: 0.342, p<0.01), psychological health (r:0.245, p<0.05), social relation (r:0.298, p<0.05) which are factors of WHOQOL-BREF were statistically significant. However, there was no statistically significant among HbA1C antidiabetic drugs and quality of life. Conclusion: Results showed that as the duration of diabetes getting increase, quality of life getting poorer. There were no effects of glycemia regulation and antidiabetic drugs on quality of life. That's why, treatment plan should be manage according to psychiatry and geriatry professionals's opinions in patients with Type 2 Diabetes Mellitus who have duration of diabetes more.

Özet

Amaç: Tip 2 Diabetes Meilituslu hastalarda, glisemi regülasyonu, diabet yılı ve kullanılan antidiabetik tedavi 'ile yaşam kalitesi ölçeği arasındaki ilişkinin incelenmesidir. Gereç ve Yöntem: Çalışmamıza; Merzifon Hava Hastanesi Diabet polikliniğince takip edilen, Tip 2 diabetik hastalar dahil edildi. Tüm hastalara aynı psikolog tarafından yüzyüze görüşme yapılarak Yaşam Kalitesi Ölçeği (WHOQOL-BREF) uygulandı. Çalışmaya dahil edilen hastaların açlık glisemi, glikolize hemoglobin (HbA1C), vücut kitle indeksi (VKi), kolesterol ve trigliserid değerleri ölçülerek, yaşam kalitesi skorları (yaşam kalitesi toplam skoru ve bunu oluşturan; genel sağlık, fiziksel sağlık, psikolojik sağlık, sosyal ilişkiler, çevresel alanla ilişki altgrupları) ölçüldü ve glisemi regülasyonu, diabet yılı ve kullanılan antidiabetik tedavi ile aralarındaki ilişki incelendi. Bulgular: Çalışmaya 108 Tip 2 diabetik hasta (68 kadın/40 erkek, ortalama yaş: 60.54±10.33) dahil edildi. Hastaların ortalama diabet yılı, VKi, HbA1C, glisemi, kolesterol ve trigliserid düzeyleri sırasıyla; 7.Ö7±6.17 yıl, 31.18±3.83 kg/m2, %7.62±1.56, 166.56±47.03 mg/dl, 208.79±44.19 mg/dl, 142.92±66.27 mg/dl idi. Diabet yılı ile yaşam kalitesi toplam skoru (r: -0.129, p<0.01), fiziksel sağlık (r:-0.129, p<0.01), psikolojik sağlık (r: -0.129, p<0.01), sosyal ilişkiler altgrubu (r: -0.194, p<0.05) arasında anlamlı derecede korelasyon mevcuttu. Diabet komplikasyonları ile yaşam kalitesi toplam skoru (r: 0.342, p<0.01), psikolojik sağlık (r: 0.245, p<0.05), sosyal ilişkiler altgrubu (r: 0.298, p<0.05) arasında da anlamlı derecede korelasyon mevcuttu. HbA1C ve kullanılan antidiabetik tedavi ile yaşam kalitesi toplam skoru ve alt grup skorları arasında istatistiki anlamlı korelasyon saptanmadı. Sonuç: Tip 2 diabetik hastaların özellikle diabet yılının artışı ile yaşam kaliteleri bozulmaktadır. Glisemi regülasyonu ve kullanılan antidiabetik tedavinin şekli, yaşam kalitelerini etkilememektedir. Bu nedenle de, diabet yılı ileri olan Tip 2 diabetik hastaların tedavileri planlanırken psikiyatri ve geriatri uzmanlarının da görüşlerinin alınmasının uygun olacağı kanaatindeyiz.

🔖

Cite This Article

GÖZAYDIN, M., DUYGUN, T., SAYGILARLI, İ., HAKSEVER, N. (2003). Relation among Glycemia regulation, duration of diabetes and quality of life in patients with type 2 diabetes mellitus. Medical Network Klinik Bilimler ve Doktor, Cilt: 9 - Sayı: 6, 670–674. https://ajindex.com/articles/278664

References (11)

  1. DeFronzo R, Ferrannini E. The pathogenesis of non-insulin- dependent diabetes: An update. Medicine 1982; 61:125-40.
  2. Efendic S, Luft R, Wajngot A. Aspects of the pathogenesis of type 2 diabetes. Endocrinol Rev. 1984; 5:395-410. Fajans SS. Diabetes Mellitus. Classification and testing procedures. Endocrinology. (Eds) De Groot LJ, Besser GM, Cahili GF Jr, Marshall JC, Nelson DH, Odell WD, Potts JT.Jr, Rubenstein AH, Steinberger E. Second edition. Philadelphia, PA. W.B. Sounders Comp.: 1989; 2:1346-56. Olefsky JM. Pathogenesis of non-insulin-dependent (Type II) diabetes. Endocrinology. (Eds) De Groot LJ, Besser GM, Cahili GF. Jr, Marshall JC, Nelson DH, Odell WD, Potts JT.Jr, Rubenstein AH, Steinberger E. Second edition. Philadelphia, PA. W.B. Sounders Comp.: 1989; 2:1369-88.
  3. Ward WK, Beard JC, Halter JB, Pfeiffer MA, Porte D. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 1984; 7:491-502.
  4. Weir GC, Leahy JL Pathogenesis of non insulin dependent (type II). Diabetes Mellitus. Joslin's Diabetes Mellitus. (Eds) Kahn CR, Weir GC. Thirtheenth edition: Lea & Febiger Waverly Company: 1994; 240-64. DeFronzo R. The triumvirate: b-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37:667-87.
  5. Unger RH, Grundy S. Hyperglicemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implication for the management of diabetes. Diabetologia 1985; 28:119-21.
  6. Anderson RJ, Freedland KE, Clause RE, Lustmari PJ. The prevelance of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care, 2001; 24:1069-78. 1 Gavard JA, Lustman PJ, Clause RE. Prevalance of depression in adults with diabetes: an epidemiologic evaluation. Diabetes Care 1993; 16:1167-78.
  7. Jacobson AM, DeGroot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care, 1994; 17:267-74.
  8. Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG. A comparison of global versus disease spesific quality of life mea­ sure in patients with NIDDM. Diabetes Care, 1997; 20:299-305.
  9. Mayou R, Bryant B, Turner R. Quality of Life in Non-Insulin Dependent Diabetes as a Comparison with Insulin-Dependent Diabetes. J. Psychosom. Res., 1990; 34:1-11.
  10. Lloyd CE, Matthews KA, Wing RR. Psychosocial Factors and the Complications of IDDM. Diabetes Care 1992; 15:166-72.
  11. Kotsanos JG, Vignati L, Huster W, et al. Health-related quality-of-life results from multinati